BVF PARTNERS L P/IL Insider Trading Activity

Average Profitability
9.57%
Insider Buys Quantity
179
Insider Buys Sum
$402.35M
Insider Sells Quantity
55
Insider Sells Sum
$401.8M

Insider Activity of BVF PARTNERS L P/IL

According to the SEC Form 4 filings, BVF PARTNERS L P/IL, being in a position of

  1. See Remarks and Footnotes at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1630658 shares for $173.67M,
    over all time since 2021-07-01, has bought 2263687 shares for $87.04M, and sold 1630658 shares for $173.67M.

Biography of BVF PARTNERS L P/IL

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $236,627,5772100

Comparison of Insiders on Amount of Buys and Sells

2026-06-26SaleKymera Therapeutics, Inc.
KYMR
See Remarks and Footnotes
1.63M
1.8128%
$106.50$173.67M+5.51%
2026-03-31SaleMoonLake Immunotherapeutics
MLTX
3.75M
4.7092%
$16.79$62.96M-7.67%
2025-06-30PurchaseKymera Therapeutics, Inc.
KYMR
See Remarks and Footnotes
317,167
0.4911%
$44.00$13.96M+67.76%
2024-10-04SaleMoonLake Immunotherapeutics
MLTX
2M
2.9134%
$50.00$100M-14.76%
2024-05-09PurchaseEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
1.93M
7.8677%
$2.37$4.57M+29.58%
2023-11-03PurchaseKymera Therapeutics, Inc.
KYMR
director
197,699
0.3518%
$14.07$2.78M+159.29%
2023-11-02PurchaseKymera Therapeutics, Inc.
KYMR
director
216,406
0.3771%
$11.64$2.52M+205.22%
2023-09-12PurchaseOlema Pharmaceuticals, Inc.
OLMA
1.51M
2.9937%
$9.84$14.82M+1.96%
2023-05-05PurchaseEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
1.98M
11.9399%
$2.31$4.57M-41.79%
2023-01-12PurchaseKymera Therapeutics, Inc.
KYMR
director
18,897
0.0302%
$31.24$590,391-27.04%
2023-01-11PurchaseKymera Therapeutics, Inc.
KYMR
director
22,110
0.038%
$29.89$660,799-18.06%
2022-11-08PurchaseRain Therapeutics Inc.
RAIN
director
1.71M
5.3616%
$5.83$9.97M
2022-01-31PurchaseKymera Therapeutics, Inc.
KYMR
director
34,408
0.0646%
$40.70$1.4M-33.05%
2022-01-27PurchaseKymera Therapeutics, Inc.
KYMR
director
95,901
0.1917%
$38.33$3.68M-24.25%
2022-01-24PurchaseKymera Therapeutics, Inc.
KYMR
director
272,767
0.4999%
$37.76$10.3M-29.51%
2022-01-07PurchaseRain Therapeutics Inc.
RAIN
496,385
1.8708%
$12.00$5.96M
2022-01-06PurchaseRain Therapeutics Inc.
RAIN
61,343
0.2241%
$12.00$736,018
2021-11-30PurchaseOlema Pharmaceuticals, Inc.
OLMA
739,675
1.9974%
$9.39$6.95M-52.69%
2021-09-21PurchaseRain Therapeutics Inc.
RAIN
11,033
0.0404%
$13.94$153,829
2021-09-13PurchaseRain Therapeutics Inc.
RAIN
392,269
1.4377%
$16.49$6.47M
Total: 182
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.